Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Benign prostatic hyperplasia (BPH) is an extremely common disease of older men, occurring in more than 70 percent of men over the age of 60. BPH results in substantial morbidity in this patient ...

Treatment options range from lifestyle modifications to medications and surgical procedures. Benign Prostatic Hyperplasia (BPH) is diagnosed through a combination of medical history, physical ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ...

Thursday, 13 March 2025 is World Kidney Health Day, with this year’s theme being "Are Your Kidneys OK? Detect Early, Protect ...

The study included 1,369 patients with clinically detected BPH (median age 66 years ... which included sections about sociodemographic factors, medical history and family history of cancer.

Medscape Medical News, February 10, 2022 Lawsuit Brings Renewed Attention to Finasteride Adverse Events Canadian and British regulatory authorities have added warnings about depression and suicide ...

Based on drug type, the global Benign Prostatic Hyperplasia Surgical Treatment market can be divided into three segments: alpha-blockers (α-blockers), 5-alpha reductase inhibitors (5-ARIs), and ...

Men seeking urologic care, either through self-referral or clinician referral, often have knowledge gaps in BPH symptoms and treatment.